These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 29500811)
1. Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial. Moon J; Kim DY; Lee WJ; Lee HS; Lim JA; Kim TJ; Jun JS; Park B; Byun JI; Sunwoo JS; Lee ST; Jung KH; Park KI; Jung KY; Kim M; Lee SK; Chu K Neurotherapeutics; 2018 Jul; 15(3):785-795. PubMed ID: 29500811 [TBL] [Abstract][Full Text] [Related]
2. A prospective, 1-year follow-up study of postural tachycardia syndrome. Kimpinski K; Figueroa JJ; Singer W; Sletten DM; Iodice V; Sandroni P; Fischer PR; Opfer-Gehrking TL; Gehrking JA; Low PA Mayo Clin Proc; 2012 Aug; 87(8):746-52. PubMed ID: 22795533 [TBL] [Abstract][Full Text] [Related]
3. Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience. Kanjwal K; Karabin B; Sheikh M; Elmer L; Kanjwal Y; Saeed B; Grubb BP Pacing Clin Electrophysiol; 2011 Jun; 34(6):750-5. PubMed ID: 21410722 [TBL] [Abstract][Full Text] [Related]
4. Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review of observational and interventional studies. Knoop I; Picariello F; Jenkinson E; Gall N; Chisari C; Moss-Morris R Auton Neurosci; 2023 Jan; 244():103052. PubMed ID: 36525900 [TBL] [Abstract][Full Text] [Related]
5. Short-term efficacy of ORS formulation and propranolol regimen in children with POTS. Yozgat Y; Temur HO; Coban S; Oner T; Karaarslan U; Yozgat CY; Karadeniz C; Ergor SN; Erenberk U Arch Pediatr; 2020 Aug; 27(6):328-332. PubMed ID: 32651146 [TBL] [Abstract][Full Text] [Related]
6. Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone. Freitas J; Santos R; Azevedo E; Costa O; Carvalho M; de Freitas AF Clin Auton Res; 2000 Oct; 10(5):293-9. PubMed ID: 11198485 [TBL] [Abstract][Full Text] [Related]
7. Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome. Moon J; Kim DY; Byun JI; Sunwoo JS; Lim JA; Kim TJ; Shin JW; Lee WJ; Lee HS; Jun JS; Park KI; Jung KH; Lee ST; Jung KY; Chu K; Lee SK Health Qual Life Outcomes; 2016 Oct; 14(1):144. PubMed ID: 27729043 [TBL] [Abstract][Full Text] [Related]
8. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Raj SR; Black BK; Biaggioni I; Paranjape SY; Ramirez M; Dupont WD; Robertson D Circulation; 2009 Sep; 120(9):725-34. PubMed ID: 19687359 [TBL] [Abstract][Full Text] [Related]
9. Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome. Fu Q; Vangundy TB; Shibata S; Auchus RJ; Williams GH; Levine BD Hypertension; 2011 Aug; 58(2):167-75. PubMed ID: 21690484 [TBL] [Abstract][Full Text] [Related]
10. Pyridostigmine in the treatment of orthostatic intolerance. Gales BJ; Gales MA Ann Pharmacother; 2007 Feb; 41(2):314-8. PubMed ID: 17284509 [TBL] [Abstract][Full Text] [Related]
11. Reversible sympathetic vasomotor dysfunction in POTS patients. Freitas J; Santos R; Azevedo E; Costa O; Carvalho M; de Freitas AF Rev Port Cardiol; 2000 Nov; 19(11):1163-70. PubMed ID: 11201632 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin in the treatment of postural orthostatic tachycardia syndrome. Kanjwal K; Saeed B; Karabin B; Kanjwal Y; Sheikh M; Grubb BP Am J Ther; 2012 Mar; 19(2):92-5. PubMed ID: 20838326 [TBL] [Abstract][Full Text] [Related]
13. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder. Benarroch EE Mayo Clin Proc; 2012 Dec; 87(12):1214-25. PubMed ID: 23122672 [TBL] [Abstract][Full Text] [Related]
14. Splanchnic Venous Compression Enhances the Effects of ß-Blockade in the Treatment of Postural Tachycardia Syndrome. Smith EC; Diedrich A; Raj SR; Gamboa A; Shibao CA; Black BK; Peltier A; Paranjape SY; Biaggioni I; Okamoto LE J Am Heart Assoc; 2020 Jul; 9(14):e016196. PubMed ID: 32673517 [TBL] [Abstract][Full Text] [Related]
15. Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies. Mar PL; Raj SR Annu Rev Med; 2020 Jan; 71():235-248. PubMed ID: 31412221 [TBL] [Abstract][Full Text] [Related]
16. Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial. Kotecha D; Bunting KV; Gill SK; Mehta S; Stanbury M; Jones JC; Haynes S; Calvert MJ; Deeks JJ; Steeds RP; Strauss VY; Rahimi K; Camm AJ; Griffith M; Lip GYH; Townend JN; Kirchhof P; JAMA; 2020 Dec; 324(24):2497-2508. PubMed ID: 33351042 [TBL] [Abstract][Full Text] [Related]
17. Serum Activity Against G Protein-Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome. Kharraziha I; Axelsson J; Ricci F; Di Martino G; Persson M; Sutton R; Fedorowski A; Hamrefors V J Am Heart Assoc; 2020 Aug; 9(15):e015989. PubMed ID: 32750291 [TBL] [Abstract][Full Text] [Related]
18. Droxidopa in the Treatment of Postural Orthostatic Tachycardia Syndrome. Ruzieh M; Dasa O; Pacenta A; Karabin B; Grubb B Am J Ther; 2017; 24(2):e157-e161. PubMed ID: 27563801 [TBL] [Abstract][Full Text] [Related]
19. Use of methylphenidate in the treatment of patients suffering from refractory postural tachycardia syndrome. Kanjwal K; Saeed B; Karabin B; Kanjwal Y; Grubb BP Am J Ther; 2012 Jan; 19(1):2-6. PubMed ID: 20460983 [TBL] [Abstract][Full Text] [Related]
20. [Pyridostigmine in the treatment of postural orthostatic tachycardia syndrome]. Can I; Tholakanahalli V Turk Kardiyol Dern Ars; 2014 Sep; 42(6):553-5. PubMed ID: 25362946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]